EBITDA for CME Group (CME)
According to CME Group's latest reported financial statements, the company's current EBITDA (TTM) is $5.69B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
CME
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$5.69B
YoY change
+13.5%
5Y CAGR
+11.3%
Peak year (2025)
$5.72B
Cumulative EBITDA
$58.62B
EBITDA history chart for CME Group (CME) from 2000 to 2025
EBITDA history table for CME Group (CME) from 2000 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $5.72B | +13.5% | ||
| 2024 | $5.04B | +8.0% | ||
| 2023 | $4.67B | +16.2% | ||
| 2022 | $4.02B | +2.3% | ||
| 2021 | $3.93B | +17.1% | ||
| 2020 | $3.35B | +0.4% | ||
| 2019 | $3.34B | +4.9% | ||
| 2018 | $3.18B | +11.7% | ||
| 2017 | $2.85B | +8.2% | ||
| 2016 | $2.64B | +14.5% | ||
| 2015 | $2.30B | +8.4% | ||
| 2014 | $2.12B | +6.7% | ||
| 2013 | $1.99B | -4.2% | ||
| 2012 | $2.08B | -10.2% | ||
| 2011 | $2.31B | +9.1% | ||
| 2010 | $2.12B | +16.3% | ||
| 2009 | $1.82B | +14.5% | ||
| 2008 | $1.59B | +30.6% | ||
| 2007 | $1.22B | +75.1% | ||
| 2006 | $696.18M | +27.5% | ||
| 2005 | $545.85M | +32.4% | ||
| 2004 | $412.35M | +59.1% | ||
| 2003 | $259.14M | +15.2% | ||
| 2002 | $224.88M | +39.3% | ||
| 2001 | $161.48M | +535.6% | ||
| 2000 | $25.41M | — |
EBITDA values are taken from CME Group's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of CME Group (CME) EBITDA is $5.72B – grew 13.5% year-over-year.
Through 2020–2025 (5 years), CME Group EBITDA delivered a +11.3% annualised rate; sustaining 12 straight years of year-over-year growth.
$5.72B stands as the all-time-high annual EBITDA, posted in 2025, against a low of $25.41M during 2000.
Within Financial Services, CME Group (CME) ranks 9th among 8 peers we track. The peer median for EBITDA is $27.98B.
CME Group EBITDA by Year
CME Group EBITDA 2025: $5.72B
CME Group EBITDA in 2025 was $5.72B, grew 13.5% from 2024. This figure represents the highest annual value in the available history.
CME Group EBITDA 2024: $5.04B
CME Group EBITDA in 2024 was $5.04B, grew 8.0% from 2023.
CME Group EBITDA 2023: $4.67B
CME Group EBITDA in 2023 was $4.67B, grew 16.2% from 2022.
CME Group EBITDA 2022: $4.02B
CME Group EBITDA in 2022 was $4.02B, edged up 2.3% from 2021.
CME Group EBITDA 2021: $3.93B
CME Group EBITDA in 2021 was $3.93B.
See more financial history for CME Group (CME).
Sector peers — EBITDA
Companies in the same sector as CME Group, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| JPMorgan Chase & Co. (JPM) | $81.42B | Financial Services |
| Berkshire Hathaway Inc. (BRK-B) | $73.02B | Financial Services |
| Bank of America Corporation (BAC) | $40.01B | Financial Services |
| Wells Fargo & Company (WFC) | $29.35B | Financial Services |
| Morgan Stanley (MS) | $26.61B | Financial Services |
| Visa Inc. (V) | $26.00B | Financial Services |
| The Goldman Sachs Group, Inc. (GS) | $24.03B | Financial Services |
| Mastercard Incorporated (MA) | $20.19B | Financial Services |
Frequently asked questions
What is CME Group's EBITDA?
- Latest reported EBITDA for CME Group (CME) is $5.69B (period ending March 31, 2026).
How has CME Group EBITDA changed year-over-year?
- CME Group (CME) EBITDA changed +13.5% year-over-year on the latest annual filing.
What is the long-term growth rate of CME Group EBITDA?
- CME Group (CME) EBITDA compound annual growth rate is +11.3% over the most recent 5 years available.
When did CME Group EBITDA hit its highest annual value?
- CME Group EBITDA reached its highest annual value of $5.72B in 2025.
What was CME Group EBITDA in 2024?
- CME Group (CME) EBITDA in 2024 was $5.04B.
What was CME Group EBITDA in 2025?
- CME Group (CME) EBITDA in 2025 was $5.72B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
CME Overview
Company profile, financial tools, and key metrics
CME Revenue Counter
Earns $214.31 every second. See per minute, hour, and day.
CME Earnings Counter
Earns $134.53 per second net profit. See per minute, hour, and day.
CME Economic Scale
Exceeds French Polynesia's GDP. Compare with world economies.
CME What If Invested
What if you had invested $1,000? See historical returns from any date.
CME How It Makes Money
Discover visual breakdown of $6.76B in revenue — where it comes from and where it goes.
CME Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
CME Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
CME Daily Price Character
Balanced · 52.3% historical win rate (green days). Streaks & record days.
CME Buybacks
0.53% TTM buyback yield. Shareholder yield & SBC comparison.
CME Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
CME Dividend Profile
Yield: 3.90%. Safety: 5/8. See full history.
CME Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
CME Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.